Clinical Trials Browser

Carcinoma, Hepatocellular × envafolimab × Gastrointestinal × Clear all

NCT05024214 2025-05-29

Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors

Phase 1/2 Recruiting

GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular

NCT06498622 2024-07-12

Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular